X
Servier and Oncodesign announce Parkinson’s R&D tie-up
https://pharmaphorum.com/news/servier-and-oncodesign-announce-parkinsons-rd-tie-up/
Servier
Servier expands global footprint post Shire deal
Following its acquisition of Shire’s oncology business in April, Servier is taking steps to expand its presence in the US and China.
Shire’s $2.4bn oncology sell-off seen as Takeda spoiler
Move seen as attempt to fend off Takeda takeover
Safety restrictions spell the end for Servier osteoporosis drug
Sales of Protelos hit by safety restrictions.
Servier and Pfizer begin trials for off-the-shelf T-cell cancer therapy
Companies hope to challenge traiblazers Novartis and Kite.
